Iluka Resources Ltd (ASX:ILU) is a Perth-headquartered mineral sands and rare earths producer with operations and projects centred on Western Australia and New South Wales. Historically the company has been one of the dominant global suppliers of zircon, used in ceramics, refractories, sanitaryware and specialty chemicals, alongside titanium feedstocks (rutile and synthetic rutile) that Supply the global pigment and titanium metal markets. Over the past decade, Iluka has gradually extended its footprint Downstream into separated rare earth oxides via the planned Eneabba refinery, leveraging a mineral sands by-product (monazite) that contains valuable heavy and light rare earths.

The company also retains a Royalty interest in BHP's Mining Area C iron ore operations, which provides a steady, Capital-light cash stream that has historically helped fund counter-cyclical Investment. This combination - established mineral sands, an iron ore royalty, and an emerging rare earths Business - makes Iluka one of the more distinctive resources stories on the ASX.

Sector and industry analysis

The mineral sands market has been navigating a cyclical soft patch. Zircon Demand from China's ceramics sector has lagged historical norms as the property market unwinds, while titanium feedstock demand has been mixed. Industry forecasters nevertheless expect modest single-digit demand growth through the early 2030s, underpinned by urbanisation in non-China Asia, premium ceramics and rising use of titanium in aerospace and renewables.

The rare earths story is more dramatic. Heavy rare earths such as dysprosium and terbium are critical inputs to the high-strength permanent magnets used in electric-vehicle traction motors, wind turbines and defence applications. Today, separation capacity for these elements sits overwhelmingly in China. Western governments - including in Canberra, Washington, Tokyo and Brussels - have responded with policy support and capital commitments. Iluka's Eneabba refinery is one of very few non-Chinese projects with the funding, ore feedstock and government backing to deliver separated heavy rare earths at meaningful scale this decade.

Why the stock deserves a Buy rating

Buy rating on Iluka is a structural call. In the near term the income statement is messy: weaker zircon pricing weighed on 2025 Earnings, the Dividend was reduced, and growth capex on Balranald and Eneabba consumes cash. But the strategic positioning is the prize. With non-recourse government Debt funding the rare earths refinery and Australian taxpayers effectively sharing the downside, Equity holders retain the bulk of the upside if pricing and operating performance meet plan.

By 2027-2028, if Eneabba commissions on schedule and Balranald reaches steady-state production, Iluka's earnings mix will look fundamentally different: a global zircon and titanium producer with long-duration mine life and a stand-alone, high-Margin separated rare earth oxide business. That is not a small re-rating opportunity if delivered.

Key growth drivers

Three projects define the growth profile. Balranald, in New South Wales, began producing heavy mineral concentrate in late 2025 using a novel underground mining technique that targets rutile-rich ore previously considered uneconomic. Ramp-up to steady-state HMC production is targeted for the middle of 2026 - a key fundamental milestone for the stock.

Eneabba is the headline event. The fully integrated refinery, with a revised capital cost in the AUD 1.7-1.8 billion range, is targeted for commissioning in 2027. It will separate light and heavy rare earth oxides directly from a stockpile of monazite-rich by-product accumulated over decades of mineral sands mining at Eneabba - a remarkable strategic asset. The Australian Government's AUD 1.65 billion non-recourse Critical Minerals Facility Loan dramatically de-risks the equity story.

Beyond these, Iluka retains optionality on additional rare earth feedstocks and synergistic mineral sands developments. The Mining Area C iron ore royalty continues to throw off cash that supports the Balance Sheet through the investment phase.

Dividend discussion

Iluka has a flexible dividend policy linked to free Cash Flow rather than a fixed Payout Ratio, which is appropriate for a cyclical resources business. The 2025 dividend was reduced to reflect softer Commodity prices and growth capex commitments, taking the trailing Yield well below 1%.

Investors should not buy Iluka primarily for income at this stage of the cycle.

Risks investors should watch

Commodity price risk is the dominant near-term concern. Zircon and titanium feedstock prices remain sensitive to Chinese property activity and global construction. A further leg down in zircon would delay both cash flow and dividend recovery.

Rare earths offtake risk is the most idiosyncratic Factor. Iluka does not yet have binding long-term contracts for the full slate of Eneabba production at commercial terms. Pricing structure, customer concentration and the strategic willingness of Western magnet manufacturers to pay a premium for non-China supply are all open questions.

China risk runs through both stories. China dominates downstream rare earths processing and could use pricing or trade policy levers to make life harder for emerging non-Chinese producers. Project execution risk on Eneabba - capital costs, schedule, commissioning - is the other obvious Tail risk, although the funding structure shields the equity to a meaningful degree.

What could move the share price next

Catalysts in the next 12 months include the Balranald ramp-up confirmation, ongoing Eneabba construction updates, and any rare-earth offtake or pricing announcements. Quarterly cash-flow trajectory will matter more than reported earnings in coming quarters.

Strategic catalysts include further policy support from the Australian Government, additional Western capital allocation to non-China rare earth supply, and any consolidation or Partnership activity in the global rare earths refining space. A move higher in zircon or titanium prices would also provide a tactical lift to the existing earnings base.

On the downside, a delay or capex Blowout at Eneabba would weigh heavily, as would softer rare earth basket pricing if the EV demand profile disappoints.

Capital Structure and balance sheet considerations

Iluka's balance sheet has been a frequent topic of debate. Heavy capex commitments at Eneabba and Balranald in 2025-2026 have inflated drawn debt levels, but the structure of the Critical Minerals Facility loan is fundamentally non-recourse to existing operations. That is a meaningful structural protection: if the rare earths refinery underperforms, the lenders' recourse is principally to the refinery's own cash flows rather than the broader mineral sands business. The Mining Area C royalty is a particularly useful counter-cyclical asset, throwing off steady cash through the investment phase regardless of where mineral sands prices sit.

Net debt should peak in 2026 as Eneabba capex completes, then decline as Balranald cash flow builds and Eneabba commissions. By the time the refinery is operating at scale, the Leverage profile should normalise. For investors comfortable with the typical mining-company gearing cycle, the trajectory is well-understood and visible.

Balanced conclusion supporting Buy

Iluka Resources is a cyclical resources business going through a heavy investment phase with a low dividend and short-term earnings Volatility. But it is also one of very few Western-listed names with funded, near-term exposure to separated heavy rare earth oxide production - a category that policymakers globally are trying to nurture into existence. Combine that with an established mineral sands earnings base and a long-life iron ore royalty, and the risk-reward looks asymmetric for patient capital.